Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata

    Eingun James Song
    Image of study
    TLDR Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.
    This article discusses a case of severe alopecia areata with a predominant ophiasis pattern, where the patient partially responded to baricitinib 4 mg daily and oral minoxidil over 15 months. However, after the addition of dupilumab, the patient experienced near complete hair regrowth within just 2 months. This case highlights the potential of using combination immunomodulatory agents, such as dupilumab, to enhance treatment responses in refractory cases of alopecia areata, especially when initial treatments with JAK inhibitors like baricitinib do not achieve desired outcomes.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 4 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 1 year ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Olumiant alternative for Alopecia Areata?

      in Treatment  1 upvotes 2 years ago
      A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

    Related Research

    1 / 1 results